| Click for the Finfacts Ireland Portal Homepage |

Finfacts Business News Centre

 Irish Economy
 EU Economy
 US Economy
 UK Economy
 Global Economy
 Asia Economy


How to use our RSS feed

Web Finfacts

See Search Box lower down this column for searches of Finfacts news pages. Where there may be the odd special character missing from an older page, it's a problem that developed when Interactive Tools upgraded to a new content management system.


Finfacts is Ireland's leading business information site and you are in its business news section.

We provide access to live business television and business related videos from: Bloomberg TV; The Wall Street Journal; CNBC and the Financial Times. Click image:


Finfacts Homepage

Irish Share Prices

Euribor Daily Rates

Irish Economy

Global Income Per Capita

Global Cost of Living

Irish Tax 2008

Climate Change Reports

Global News

Bloomberg News

CNN Money

Cnet Tech News


Irish Independent

Irish Times

Irish Examiner

New York Times

Financial Times

Technology News




Content Management by interactivetools.com.

News : Irish Last Updated: Apr 24, 2009 - 5:31:05 PM

 Boston Scientific to invest €50 million in Galway Research and Development facility
By Finfacts Team
Sep 8, 2008 - 3:02:16 PM

Email this article
 Printer friendly page

Boston Scientific Corporation is the world's largest medical device company dedicated to less-invasive therapies. Its products and technologies reduce risk, trauma, cost, procedure time and the need for aftercare. Boston Scientific's healthcare manufacturing facility in Galway, Ireland - incorporating major clean room areas and testing facilities.

Minister for Finance, Brian Lenihan T.D today announced that Boston Scientific Corporation, which specialises in medical devices for use in minimally invasive surgical procedures, is to invest €50 million, with the support of IDA Ireland, in strategic Research and Development at its Galway facility.

Boston Scientific was established in Galway in 1994 and is the largest manufacturing site within the corporation with over 3,000 people employed in the R&D and manufacture of cardiology and peripheral vascular products such as stents and catheters.  This is a major investment for the company and an integral part of its strategic plans.

Lenihan, welcoming the investment, said “This investment is extremely significant, not just for Galway but also in terms of the research and development activities that are taking place in Ireland.  Boston Scientific is a highly technologically advanced company which has to rapidly change and continually develop to remain ahead in a highly competitive industry. Their desire to locate this investment here speaks very highly of the calibre of Irish scientific talent.”

“The R&D investment will bring major technical enhancement in innovation and skills to the Galway facility, which has already gained a valuable reputation within Boston Scientific Corporation for its successful development of drug-eluting stent products, through commercialisation to approval and global volume launch.”concluded the Minister.

This investment will further underpin both R&D and manufacturing at the Galway facility and will broaden significantly the capabilities of the R&D team responsible for new product development, which directly employs over 200 people.

Jim Tobin, CEO of Boston Scientific who visits the Galway plant this week said “We are very pleased to be announcing this investment in Ireland. The Galway R&D team have an impressive talent base and a strong track record of delivering innovation.  We look forward to their continuing contributions.”

CEO, IDA Ireland, Barry O’Leary, also noted “At €50m this is one of the most significant Research and Development investments supported by IDA Ireland, given the stature of the Boston Scientific Corporation it demonstrates Ireland’s ability to win such investments internationally and demonstrates our ability as a capable knowledge based economy”

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. 

Boston Scientific, founded in 1979 and headquartered in Natick, Massachusetts, US, is a public company listed on the NYSE (BSX).  It employs 25,000 people in 26 manufacturing, distribution and technology centres worldwide. It had revenues of $8.3 billion in 2007.  R&D spend in 2007 was 13% of revenues – over $1 billion. 

Related Articles
Related Articles

© Copyright 2009 by Finfacts.com

Top of Page

Latest Headlines
Ryanair revises up full-year profit guidance
AIB bank profitable in third quarter
Ryanair announces half-year profits up 32% to €795m
Ryanair benefits from improved customer service
Ryanair to buy 100 new Boeing 737 MAX 200
Finfacts server migration Thursday
State-owned Allied Irish Banks reports H1 2014 profit as bad loan charges plunge
Ryanair reports profit in its financial first quarter soared 152%
UK firm opens van dealership in Dublin
Ryanair reports 8% fall in full-year profit; US services to commence in 2019
Global Financial Centres Index: New York overtakes London; Dublin slips to 66 of 83 cities
Bank of Ireland reports “significant” improvement in 2013 results
Sale process of IBRC UK projects Rock and Salt completed
CRH says 2014 will be year of profit growth after reporting 2013 loss
Ryanair reports third-quarter loss
Irish Water says it saved €100m in setup costs
RSA Insurance fires two Irish executives for large loss/ accounting irregularities
Bank of Ireland will have to raise provisions by €1.4bn; AIB says it's "well capitalised"
CRH reports slightly improved third quarter
Central Bank says ownership of Newbridge Credit Union transferred to permanent tsb
Ryanair reports H1 profits rose by 1% to €602m
Dublin Web Summit: Irish Stock Exchange and NASDAQ OMX announce dual listing plan
Irish pension managed funds returned to growth during September
Dan O’Brien resigns as economics editor of The Irish Times
Central Bank says no action required on Anglo tapes revelations
Ryanair flew 9m passengers and Aer Lingus carried 1.1m in August
UK Competition Commission says Ryanair must cut Aer Lingus stake to 5%
CRH reports H1 2013 revenue dip and loss
Vodafone refunded UK after discovery of Irish tax haven deal
RBS reports half year profit; Ulster Bank posts reduced loss
Bank of Ireland cuts pretax losses in HI 2013 to €504m
Irish State-owned Allied Irish Banks reports losses of €758m in H1 2013
Service Announcement
Irish managed pension funds declined in June
VHI reports 2012 surplus of €54.3m; Health insurance made loss
Ex- Elan director says management / board "not competent to run a business"
Aer Lingus to put €140m in employees pensions fund; Ryanair apoplectic
Wednesday Newspaper Review - Irish Business News and International Stories - - May 22, 2013
Tuesday Newspaper Review - Irish Business News and International Stories - - May 21, 2013
Ryanair, Europe’s biggest low cost carrier, announced Monday record annual profits of €569m - - up 13%